• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Analysis of phencyclidine-induced disruption of acoustic startle in rat

Research Project

Project/Area Number 10680726
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Neurochemistry/Neuropharmacology
Research InstitutionKurume University School of Medicine

Principal Investigator

YAMADA Shigeto  Associate Professor, Institute of Brain Diseases, 医学部, 助教授 (20158190)

Co-Investigator(Kenkyū-buntansha) YOSHIDA Masami  Associate Professor, Pharmacology, 医学部, 助教授 (50148285)
TANAKA Masatoshi  Professor, Pharmacology, 医学部, 教授 (10080954)
久富 慎治  久留米大学, 医学部, 助手 (90320241)
Project Period (FY) 1998 – 2000
Project Status Completed (Fiscal Year 2000)
Budget Amount *help
¥3,400,000 (Direct Cost: ¥3,400,000)
Fiscal Year 2000: ¥500,000 (Direct Cost: ¥500,000)
Fiscal Year 1999: ¥900,000 (Direct Cost: ¥900,000)
Fiscal Year 1998: ¥2,000,000 (Direct Cost: ¥2,000,000)
Keywordsprepulse inhibition / phencyclidine / dopamine / serotonin / neuroleptics / SDA / プレパルス インヒビション / シグマ受容体 / prepulse inhibition / phencyclidine / セロトニン2A受容体 / ドパミンD_2受容体 / ラット
Research Abstract

The disruption of prepulse inhibiton of acoustic startle (PPI) is an animal model for some aspects of schizophrenia. Phencyclidine causes psychotomimetic symptoms in human and disrupts PPI in animals, however, the mechanism underlying this disruption remains unclear.
In the first experiment, Dopamine and 3,4-dihydroxy phenylacetic acid (DOPAC) levels in discrete regions and apomorphine- or (-)-sulpiride- induced changes in electrically evoked dopamine release from nucleus accumbens slices were assessed after testing prepulse inhibition of acoustic startle (PPI) in rats. Dopamine and DOPAC levels in the nucleus accumbens, but not in the striatum, correlated well with PPI (r=-0.64 for dopamine, r=-0.48 for DOPAC). Evoked dopamine release from the nucleus accumbens did not differ between high-PPI (more than 60 %) and low-PPI (less than 40 %) group. When slices were superfused with 1 mM apomorphine, the S2/S1 ratio in rats showing high PPI was 0.77±0.02 (mean±SEM, 66% of control), significa … More ntly smaller than in the low-PPI group (S2/S1 ratio=0.97±0.08, 94% of control, P<0.05). Moreover, (-)-sulpiride-induced increase in evoked dopamine release from the nucleus accumbens in the high-PPI group was inclined to be greater than in the low-PPI group. The results suggest that PPI differences between individuals may reflect the sensitivity of release-modulating dopamine autoreceptors in the nucleus accumbens.
In the second experiment, we tested the hypothesis that serotonin 2A receptor blocking property of drugs reverses the phencyclidine-induced PPI disruption. The ED50 value of spiperone, haloperidol, chlorpromazine, clozapine, risperidone, olanzapine, seroquel, pipamperone, mianserin or desipramine to reverse the phencyclidine- or apomorphine-induced PPI disruption in rat was determined. Then the correlation between the ED50 value and the affinity for the serotonin 2A, 2C, dopamine D2, or a-1 receptor of each drug was examined.
The ED50 value of the drugs to reverse the phencyclidine- induced PPI disruption was significantly correlated with the affinity for the serotonin 2A receptor, but not for the dopamine D2, serotonin 2C or a- 1 receptor of each drug. In contrast, the ED50 value of the drugs to reverse the apomorphine- induced PPI disruption was significantly correlated with the affinity for the dopamine D2 receptor, but not for the serotonin 2A receptor. These data indicate that an activation of serotonin 2A receptors would mediate the phencyclidine-induced PPI disruption.
All the data taken in the present project indicate that PCP-induced disruption would be caused by the stimulation of serotonergic system which was independent to dopaminergic system and be a suseful tool for investigating the pathophysiology of non-dopamine psychosis. Less

Report

(4 results)
  • 2000 Annual Research Report   Final Research Report Summary
  • 1999 Annual Research Report
  • 1998 Annual Research Report
  • Research Products

    (14 results)

All Other

All Publications (14 results)

  • [Publications] Yamada S et al: "Dopamine autoreceptors in rat nucleus accumbens modulate prepulse inhibition of acoustic startle."Pharmacol Biochem Behav. 60. 803-808 (1998)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Yamada S, et al: "Involvement of serotonin 2A receptors in phencyclidine-induced disruption of prepulse inhibition of the acoustic startle in rats."Biol.Psychiatr.. 46. 832-838 (1999)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Yamada S et al: "Effects of shigma-1 receptor ligand, MS-377 on apomorphine-or phency clidine-induced disruption of prepulse inhibition of acoustic startle in rats"Eur.J.Pharmacol.. 402. 251-254 (2000)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] 山田茂人: "精神分裂病の情報処理障害モデルとしてのprepulse inhibitionの減弱"日本神経精神薬理学雑誌. 20. 131-139 (2000)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Yamada S et al: "Dopamine autoreceptor in rat nucleus accumbens modulate prepulse inhibition of acoustic startle."Pharm Pharmacol Behav. 60. 803-808 (1998)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Yamada S et al: "Involvement of serotonin2A receptors in phencyclidine-induced disruption of prepulse inhibition of the acoustic startle in rats"Biol Psychiatr. 46. 832-838 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Yamada S et al: "Effects of shigma-1 receptor ligand, MS-377 on apomorphine- or phencyclidine-induced disruption of prepulse inhibition of acoustic startle in rats"Eur J Pharmacol. 402. 251-254 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Yamada S: "Disruption of prepuls inhibition of acoustic startle as an animal model for schizophrenia. (in japanese)"Jpn J Neuropsychopharmacol. 20. 131-139 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Yamada S et al: "Dopamine autoreceptors in rat nucleus accumbens modulate prepulse inhibition of acoustic startle."Pharmacol Blochem Behav. 60. 803-808 (1998)

    • Related Report
      2000 Annual Research Report
  • [Publications] Yamada S, et al: "Involvement of serotonin 2A receptors in phencyclidine-induced disruption of prepulse inhibition of the acoustic startle in rats."Biol.Psychiatr.. 46. 832-838 (1999)

    • Related Report
      2000 Annual Research Report
  • [Publications] Yamada S et al: "Effects of shigma-1 receptor ligand, MS-377 on apomorphine-or phency clidine-induced disruption of prepulse inhibition of acoustic startle in rats"Eur.J.Pharmacol.. 402. 251-254 (2000)

    • Related Report
      2000 Annual Research Report
  • [Publications] 山田茂人: "精神分裂病の情報処理障害モデルとしてのprepulse inhibitionの減弱"日本神経精神薬理学雑誌. 20. 131-139 (2000)

    • Related Report
      2000 Annual Research Report
  • [Publications] S.Yamada,M.Harano,N.Anno M.Tanaka: "Involvement of serotonin 2A receptorsin phencyclidine-induced disruption of prepulse inhibition of the acoustic startle in rats"Bilogical Psychiatry. 46(6). 832-838 (1999)

    • Related Report
      1999 Annual Research Report
  • [Publications] S.Yamada, M.Harano,et al.,: "Involvement of serotonin 2A receptors in phencyclidine-induced disruption of acoustic startle in rats" Biological Psychiatry. (印刷中). (1999)

    • Related Report
      1998 Annual Research Report

URL: 

Published: 1998-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi